Lexaria BioscienceLEXX
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 31 institutions reported holding Lexaria Bioscience Corp. (LEXX) in their 13F filings, up 3 from Q1 2026. 6 opened new positions and 3 sold out. The largest holders were Invenomic Capital Management LP ($194K), Vanguard Capital Management LLC ($167K) and Geode Capital Management, LLC ($140K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Lexaria Bioscience Corp.
- CUSIP
- 52886N406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $37K |
| Exits | 3 | $9K |
All 13F filers, Q1 2026 → Q2 2026: 358,107 shares bought and 207,969 shares sold, net +150,138 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Invenomic Capital Management LP | 0.01% | Reduce -21.8% | 345,685 | $194K |
| Vanguard Capital Management LLC | 0.00% | Add +34.3% | 298,436 | $167K |
| Geode Capital Management, LLC | 0.00% | Reduce -14.9% | 250,415 | $140K |
| Citadel Advisors | 0.00% | Add +1061.4% | 156,945 | $88K |
| Toronto Dominion Bank | 0.00% | Reduce -28.6% | 100,013 | $56K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 94,166 | $53K |
| HRT Financial LP | 0.00% | Add +252.3% | 65,049 | $36K |
| UBS Group AG | 0.00% | Reduce -10.9% | 46,966 | $26K |
| Northern Trust Corp. | 0.00% | Add +116.6% | 39,825 | $22K |
| State Street Corp. | 0.00% | No change | 39,301 | $22K |
| StoneX Group Inc. | 0.00% | New | 25,714 | $16K |
| BlackRock, Inc. | 0.00% | No change | 27,445 | $15K |
| Krilogy Financial LLC | 0.00% | Add +22.9% | 24,153 | $14K |
| XTX Topco Ltd | 0.00% | Reduce -11.1% | 22,298 | $12K |
| Virtu Financial LLC | 0.00% | New | 18,901 | $11K |
| Renaissance Technologies | 0.00% | Add +1.2% | 16,500 | $9K |
| Susquehanna International Group, LLP | 0.00% | New | 15,263 | $9K |
| Vontobel Holding Ltd. | 0.00% | Reduce -34.0% | 15,189 | $9K |
| Bank of Montreal | 0.00% | No change | 14,033 | $8K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 10,204 | $6K |
| Royal Bank of Canada | 0.00% | Add +0.3% | 7,159 | $4K |
| Crews Bank & Trust | 0.00% | New | 3,864 | $2K |
| Osaic Holdings, Inc. | 0.00% | Add +262.8% | 2,195 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 382 | $214 |
| FMR LLC | 0.00% | New | 213 | $119 |
| Farther Finance Advisors, LLC | 0.00% | Add +3.6% | 172 | $96 |
| Tower Research Capital LLC (TRC) | 0.00% | Add +7500.0% | 152 | $85 |
| Barclays PLC | 0.00% | New | 92 | $52 |
| Gables Capital Management Inc. | 0.00% | No change | 13 | $7 |
| Morgan Stanley | 0.00% | No change | 3 | $2 |
| SBI Securities Co., Ltd. | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is LEXX's weight in each manager's 13F, not the share of Lexaria Bioscience Corp. the manager owns.